Shopping Cart 0
Cart Subtotal
USD 0

CareDx Inc (CDNA) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

CareDx Inc, Medical Equipment, Deal Details 11

Venture Financing 11

CareDx Secures USD15 Million in Venture Funding 11

Partnerships 12

CareDx Enters into Licensing and Commercialization Agreement with Illumina 12

Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 13

CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14

CareDx to Partner with Qiagen 15

CareDx Enters into Co-Development Agreement with Horizon Discovery 16

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17

Equity Offering 18

CareDx Plans to Raise up to USD200 in Public Offering of Securities 18

CareDx Raises USD20 Million in Public Offering of Shares 19

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 21

CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 22

CareDx Raises USD9 Million in Public Offering of Shares 23

CareDx Raises USD8 Million in Private Placement of Units 25

CareDx Plans to Raise up to USD23 Million in Public offering of Shares 26

CareDx Raise USD22 Million in Private Placement of Units 27

CareDx Raises USD14 Million in Private Placement of Units 28

CareDx Raises USD40 Million in IPO 29

Acquisition 31

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 31

CareDx Inc-Key Competitors 32

CareDx Inc-Key Employees 33

CareDx Inc-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 35

Financial Announcements 35

Aug 09, 2018: Caredx reports second quarter results 35

May 10, 2018: CareDx Reports First Quarter Results 37

Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 38

Jan 08, 2018: CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results 40

Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 41

Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 42

Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients 43

Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 44

May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 45

Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 46

Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 47

Corporate Communications 49

Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 49

Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 50

Legal and Regulatory 51

Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 51

Product News 52

Oct 02, 2018: CareDx Profiles AlloSeq Suite of NGS Products at ASHI 52

Mar 18, 2018: Olerup QTYPE now available on Applied Biosystems platforms 53

Feb 05, 2018: CareDx Leadership in cfDNA Highlighted at CEoT 54

May 30, 2017: CareDx Activities at European Federation of Immunogenetics Congress 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

CareDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

CareDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

CareDx Inc, Medical Equipment, Key Facts, 2017 2

CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Deals By Market, 2012 to YTD 2018 9

CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

CareDx Secures USD15 Million in Venture Funding 11

CareDx Enters into Licensing and Commercialization Agreement with Illumina 12

Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 13

CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14

CareDx to Partner with Qiagen 15

CareDx Enters into Co-Development Agreement with Horizon Discovery 16

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17

CareDx Plans to Raise up to USD200 in Public Offering of Securities 18

CareDx Raises USD20 Million in Public Offering of Shares 19

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 21

CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 22

CareDx Raises USD9 Million in Public Offering of Shares 23

CareDx Raises USD8 Million in Private Placement of Units 25

CareDx Plans to Raise up to USD23 Million in Public offering of Shares 26

CareDx Raise USD22 Million in Private Placement of Units 27

CareDx Raises USD14 Million in Private Placement of Units 28

CareDx Raises USD40 Million in IPO 29

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 31

CareDx Inc, Key Competitors 32

CareDx Inc, Key Employees 33

CareDx Inc, Subsidiaries 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

CareDx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.